Hemp Seed Oil Wood Finish
Müller-Vahl 2. Lambert DM: Cannabinoids in Nature and Medicine. Weinheim: Wiley-Vch. Hemp Seed Oil Wood Finish verlag GmbH & Co.
Clin Rehabil 2003; 17: 18-26. MEDLINE e74. Berman JS Symonds C Birch R: Efficacy of two cannabis based medicinal extracts for relief
of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial. Pain 2004; 112: 299-306.
Volicer L Stelly M Morris J McLaughlin J Volicer BJ: Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease. Int J Geriatr Psychiatry 1997; 12: 913-9. MEDLINE e71.
MEDLINE e53. Citron ML Herman TS Vreeland F Krasnow SH Fossieck BE Jr: Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting. Cancer Treat Rep 1985; 69: 109-12.
Multiple Sclerosis 2004; 10: 425-33 MEDLINE e107. Kavia RB De Ridder D Constantinescu CS Stott CG Fowler CJ: Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler 2010; 16: 1349-59 MEDLINE e108. Müller-Vahl
Ekert H Waters KD Jurk KH Hemp Seed Oil Wood Finish Mobilia J Loughnan P: Amelioration of cancer chemotherapy-induced nausea and vomiting by ?9-tetrahydrocannabinol. Med J Aust 1979; 2: 657-9. MEDLINE e21.
Grotenhermen F: The toxicology of cannabis and cannabis prohibition. Chem Biodivers 2007; 4: 1744-69. CrossRef 15. 16. Bolla KI Brown K Eldreth D Tate K Cadet JL: Dose-related neurocognitive effects of marijuana use. Neurology 2002; 59: 1337-43.
MEDLINE e36. Ahmedzai S Carlyle DL Clader IT Moran F: Anti-emetic efficacy and toxicity of nabilone a synthetic cannabinoid in lung cancer chemotherapy. Br J Cancer 1983; 48: 657-63.
Johnson JR Burnell-Nugent M Lossignol D Ganae-Motan ED Potts R Fallon MT: Multicenter double-blind randomized placebo-controlled parallel-group study of the efficacy safety cannabidiol oil plus gold and tolerability of THC:CBD Extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage 2010; 39: 167-79. MEDLINE e88. Staquet M Gantt C Machin D: Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. what are the side effects of quitting weed smoking Clin Pharmacol Ther 1978; 23: 397-401 MEDLINE e89.
Dr. med. Müller-Vahl 2.
MEDLINE e36. Ahmedzai S Carlyle DL Clader IT Moran F: Anti-emetic efficacy and toxicity of nabilone a synthetic cbd vape wholesale cannabinoid in lung cancer chemotherapy. Br J Cancer 1983; 48: 657-63.
MEDLINE e57. American Society of Clinical Oncology Kris MG Hesketh PJ et al.: American Society of Clinical Oncology guideline for antiemetics in oncology: Update 2006. J Clin Oncol 2006; 24: 2932-47.
Wada JK Bogdon
DL Gunnell JC Hum GJ Gota CH Rieth TE: Double-blind randomized crossover trial of nabilone vs. placebo in cancer chemotherapy. Cancer Treatment Rev 1982; 9(Suppl B): 39-44.
Schwarcz G Karajgi B: Improvement in refractory psychosis with dronabinol: four case reports. J Clin Psychiatry 2010; 71: 1552-3 CrossRef MEDLINE e113. Jones RT Benowitz N Bachman J: Clinical studies of cannabis tolerance and dependence.
Pain 2007; side effects of weed sexually 133: 210-20 MEDLINE e79. Selvarajah D Gandhi R Emery CJ Tesfaye S: Randomised Placebo Controlled Double Blind Clinical Trial of Hemp Seed Oil Wood Finish Cannabis Based Medicinal Product (Sativex) in Painful Diabetic Neuropathy: Depression is a Major Confounding Factor. Diabetes Care 2010; 33: 128-30 CrossRef MEDLINE PubMed Central e80.
Noyes R Brunk ST Avery DH Canter A: The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clin Pharmacol Ther 1975; 18: 84-9 MEDLINE e87. Johnson JR Burnell-Nugent M Lossignol D Ganae-Motan ED Potts R Fallon MT: Multicenter double-blind randomized placebo-controlled parallel-group study of the efficacy safety and tolerability of THC:CBD Extract and THC extract in patients with intractable cancer-related pain.
Novotna A Mares J Ratcliffe S et al.: A randomized double-blind placebo-controlled parallel-group enriched-design study of nabiximols (Sativex) as add-on therapy in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol 2011; 18: 1122-31. MEDLINE e13.